Re-evaluation of randomized control trials of lithium monotherapy: A cohort effect

Bipolar Disorders

Volumn 7, Issue 4, 2005, Pages 382-387

  Deshauer, Dorian ^a   Fergusson, D ^b   Duffy, A ^a   Albuquerque, J ^a   Grof, P ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bipolar; Lithium; Meta analysis; Systematic review

Indexed keywords

IMIPRAMINE; LAMOTRIGINE; LITHIUM; PLACEBO; VALPROATE SEMISODIUM;

ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL STUDY; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMBASE; EXPERIMENTAL DESIGN; HUMAN; MEDLINE; META ANALYSIS; MONOTHERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PSYCINFO; QUANTITATIVE ANALYSIS; RANDOMIZATION; RECURRENT DISEASE; SYSTEMATIC REVIEW;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM CARBONATE;

EID: 23044515428     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00206.x     Document Type: Article

References (31)

1. Grof P. Has the effectiveness of lithium changed? Impact of the variety of lithium's effects. Neuropsychopharmacology 1998; 19: 183-188.
2. Feighner J, Robins E, Guze S, Woodruff R, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57-63.
3. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Devdutt DN, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. Arch Gen Psychiatry 1982; 39: 1065-1069.
4. Fieve R, Kumbaraci T, Dunner D. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976; 133: 925-928.
5. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 1973; 29: 420-425.
6. Stallone F, Shelley E, Mendlewicz J, Fieve RR. The use of lithium in affective disorders, III: a double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 1973; 130: 1006-1010.
7. Coppen A, Noguera R, Bailey J et al. Prophylactic lithium in affective disorders. Controlled Trial. Lancet 1971; 2(7719): 275-279.
8. Abou-Saleh M, Coppen A. Who responds to prophylactic lithium? J Affect Disord 1986; 10: 115-125.
9. Dunner DL, Stallone F, Fieve R. Prophylaxis with lithium carbonate: an update. Arch Gen Psychiatry 1982; 39: 1344-1345.
10. Grof P, Alda M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilizing lithium treatment. The importance of patient selection. Br J Psychiatry 1993; 163 (Suppl.): S16-S19.
11. Bowden C. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord 2001; 67: 257-265.
12. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000; 42: 2-10.
13. Bowden CL, Brugger AM, Swann AC et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271: 918-924.
14. Tohen M, Chengappa KNR, Suppes T et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62-69.
15. Grof P. Lithium update: selected issues. In: Ayd F, Taylor JT, Taylor BT eds. Affective Disorders Reassessed. Baltimore, MD: Ayd Medical Communications, 1983: 36-42.
16. Egger M, Smith GD, Altman DG (eds). Systematic Reviews in Health Care. Meta-analysis in Context, 2nd edn. London, UK: BMJ Publishing Group, 2001: 73 pp.
17. The Cochrane Library. Issue 4. Chichester, UK: John Wiley & Sons, Ltd, 2003.
18. Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand 1999; 100: 406-417.
19. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin G. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-222.
20. Baldessarini R, Tondo L, Viguera A. Discontinuing lithium maintenance treatment in bipolar disorders: risk and implications. Bipolar Disord 1999; 1: 17.
21. Schou M, Thomsen K, Baastrup PC. Studies on the course of recurrent endogenous affective disorders. Int Pharmacopsychiatry 1970; 5: 100-106.
22. Grof P, Cakuls P, Dostal T. Lithium drop-outs: a follow-up study of the patients who discontinued prophylactic lithium. Int J Pharmacopsychiatry 1971; 5: 162-169.
23. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
24. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995; 273: 408-412.
25. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders, V: a double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 1976; 33: 117-120.
26. Bowden CL, Calabrese JR, McElroy SL et al. Randomized, placebo-controlled 12-month trial divalproex and lithium treatment outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481-489.
27. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18 month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
28. Calabrese JR, Bowden CL, Sachs G et al. A placebo-controlled 18 month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 69: 1013-1024.
29. Scklo M, Javier N. Epidemiology Beyond the Basics. Gaithersburg MD: Aspen publishers, p. 3.
30. Keck PE, Welge JA, Strakowski SM, Arnold LM, McElroy SL. Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder. Biol Psychiatry 2000; 47: 756-761.
31. Nolen W, Luckenbaugh D, Altshuler L et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry 2004; 161: 1447-1454.